PortfoliosLab logoPortfoliosLab logo
NOVN.SW vs. FWRA.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

NOVN.SW vs. FWRA.L - Performance Comparison

The chart below illustrates the hypothetical performance of a CHF 10,000 investment in Novartis AG (NOVN.SW) and Invesco FTSE All-World UCITS ETF USD Accumulation (FWRA.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

NOVN.SW is traded in CHF, while FWRA.L is traded in USD. To make them comparable, the FWRA.L values have been converted to CHF using the latest available exchange rates.

Returns By Period

In the year-to-date period, NOVN.SW achieves a 8.91% return, which is significantly lower than FWRA.L's 9.92% return.


NOVN.SW

1D
2.04%
1M
2.19%
YTD
8.91%
6M
11.93%
1Y
22.96%
3Y*
14.41%
5Y*
12.76%
10Y*
9.98%

FWRA.L

1D
-0.13%
1M
3.09%
YTD
9.92%
6M
9.50%
1Y
22.24%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NOVN.SW vs. FWRA.L - Yearly Performance Comparison


2026 (YTD)202520242023
NOVN.SW
Novartis AG
8.91%27.98%8.44%0.70%
FWRA.L
Invesco FTSE All-World UCITS ETF USD Accumulation
9.92%6.96%27.35%3.36%

Correlation

The correlation between NOVN.SW and FWRA.L is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Jun 27, 2023

0.15

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NOVN.SW vs. FWRA.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOVN.SW
NOVN.SW Risk / Return Rank: 7575
Overall Rank
NOVN.SW Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
NOVN.SW Sortino Ratio Rank: 7272
Sortino Ratio Rank
NOVN.SW Omega Ratio Rank: 7272
Omega Ratio Rank
NOVN.SW Calmar Ratio Rank: 7777
Calmar Ratio Rank
NOVN.SW Martin Ratio Rank: 7777
Martin Ratio Rank

FWRA.L
FWRA.L Risk / Return Rank: 7171
Overall Rank
FWRA.L Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
FWRA.L Sortino Ratio Rank: 7676
Sortino Ratio Rank
FWRA.L Omega Ratio Rank: 7272
Omega Ratio Rank
FWRA.L Calmar Ratio Rank: 6565
Calmar Ratio Rank
FWRA.L Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOVN.SW vs. FWRA.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NOVN.SW) and Invesco FTSE All-World UCITS ETF USD Accumulation (FWRA.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NOVN.SWFWRA.LDifference
Sharpe ratioReturn per unit of total volatility

-0.40

Sortino ratioReturn per unit of downside risk

-0.65

Omega ratioGain probability vs. loss probability

1.24

1.32

-0.08

Calmar ratioReturn relative to maximum drawdown

2.29

2.96

-0.66

Martin ratioReturn relative to average drawdown

5.53

9.57

-4.04

NOVN.SW vs. FWRA.L - Sharpe Ratio Comparison

The current NOVN.SW Sharpe Ratio is 1.34, which is comparable to the FWRA.L Sharpe Ratio of 1.74. The chart below compares the historical Sharpe Ratios of NOVN.SW and FWRA.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NOVN.SWFWRA.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.34

1.74

-0.40

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.72

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.55

Sharpe Ratio (All Time)

Calculated using the full available price history

0.48

1.09

-0.61

Drawdowns

NOVN.SW vs. FWRA.L - Drawdown Comparison

The maximum NOVN.SW drawdown since its inception was -42.25%, which is greater than FWRA.L's maximum drawdown of -20.42%. Use the drawdown chart below to compare losses from any high point for NOVN.SW and FWRA.L.


Loading charts...

Drawdown Indicators


NOVN.SWFWRA.LDifference

Max Drawdown

Largest peak-to-trough decline

-42.25%

-20.42%

-21.83%

Max Drawdown (1Y)

Largest decline over 1 year

-10.78%

-7.52%

-3.26%

Max Drawdown (3Y)

Largest decline over 3 years

-16.86%

Max Drawdown (5Y)

Largest decline over 5 years

-16.86%

Max Drawdown (10Y)

Largest decline over 10 years

-24.11%

Current Drawdown

Current decline from peak

-8.53%

-1.43%

-7.10%

Average Drawdown

Average peak-to-trough decline

-11.40%

-3.02%

-8.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.43%

2.32%

+2.11%

Volatility

NOVN.SW vs. FWRA.L - Volatility Comparison

Novartis AG (NOVN.SW) has a higher volatility of 6.01% compared to Invesco FTSE All-World UCITS ETF USD Accumulation (FWRA.L) at 3.38%. This indicates that NOVN.SW's price experiences larger fluctuations and is considered to be riskier than FWRA.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NOVN.SWFWRA.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.01%

3.38%

+2.63%

Volatility (6M)

Calculated over the trailing 6-month period

13.12%

9.52%

+3.60%

Volatility (1Y)

Calculated over the trailing 1-year period

18.53%

12.82%

+5.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.81%

14.60%

+3.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.23%

14.60%

+3.63%

Dividends

NOVN.SW vs. FWRA.L - Dividend Comparison

NOVN.SW's dividend yield for the trailing twelve months is around 3.19%, while FWRA.L has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
FWRA.L
Invesco FTSE All-World UCITS ETF USD Accumulation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NOVN.SW
Novartis AG
3.19%3.19%3.72%3.77%3.91%3.94%3.72%3.27%3.98%3.98%4.35%3.58%

Frequently Asked Questions


NOVN.SW and FWRA.L have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for NOVN.SW and FWRA.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer